(Q46474917)

22 December 2017

title

Diagnosis of subclinical and clinical acute T-cell-mediated rejection in renal transplant patients by urinary proteome analysis (English)

1 reference

22 December 2017

author

Jochen Metzger

1

1 reference

22 December 2017

William Mullen

8

1 reference

22 December 2017

Harald Mischak

9

1 reference

22 December 2017

Hermann Haller

10

object named as

Hermann Haller

1 reference

22 December 2017

Eric Schiffer

4

object named as

Eric Schiffer

1 reference

22 December 2017

author name string

Christos Chatzikyrkou

2

1 reference

22 December 2017

Verena Broecker

3

1 reference

22 December 2017

Lothar Jaensch

5

1 reference

22 December 2017

Alexander Iphoefer

6

1 reference

22 December 2017

Michael Mengel

7

1 reference

22 December 2017

Wilfried Gwinner

11

1 reference

22 December 2017

publication date

29 April 2011

1 reference

22 December 2017

Proteomics - Clinical Applications

published in

1 reference

22 December 2017

volume

5

1 reference

22 December 2017

issue

5-6

1 reference

22 December 2017

page(s)

322-333

1 reference

22 December 2017

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Renal transplant rejection markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Proteomic-based detection of urine proteins associated with acute renal allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Bioinformatic analysis of the urine proteome of acute allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Shotgun proteomics identifies proteins specific for acute renal transplant rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Characterization of urinary peptide biomarkers of acute rejection in renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Common sense approaches to urinary biomarker study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Clinical proteomics: A need to define the field and to begin to set adequate standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Performance characteristics of electron transfer dissociation mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

A Decision-Theoretic Generalization of On-Line Learning and an Application to Boosting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Urinary proteomics in diabetes and CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

MMP-8 promotes polymorphonuclear cell migration through collagen barriers in obliterative bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Renal collecting duct epithelial cells react to pyelonephritis-associated Escherichia coli by activating distinct TLR4-dependent and -independent inflammatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Comprehensive human urine standards for comparability and standardization in clinical proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Meta-analyses qualify metzincins and related genes as acute rejection markers in renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Monocytes/macrophages in renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Inflammatory cells in renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Detection of Acute Tubulointerstitial Rejection by Proteomic Analysis of Urinary Samples in Renal Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Protocol biopsies in renal transplatation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

Proteomic-Based Identification of Cleaved Urinary beta2-microglobulin as a Potential Marker for Acute Tubular Injury in Renal Allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000153

21 January 2018

Identifiers

DOI

10.1002/PRCA.201000153

1 reference

22 December 2017

1 reference

22 December 2017